(Q41676214)

6 October 2017

Hormonal regulation of the menstrual cycle in women with breast cancer: effect of adjuvant chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A455742

20 May 2023

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

20 May 2023

author name string

B. M. Sherman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A455742

20 May 2023

R. B. Wallace

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A455742

20 May 2023

P. R. Jochimsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A455742

20 May 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=455742

20 May 2023

publication date

1 March 1979

1 reference

full work available at URL

6 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1979.tb02083.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1979.tb02083.x/fullpdf

20 May 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

20 May 2023

published in

Clinical Endocrinology

1 reference

6 October 2017

10

1 reference

6 October 2017

3

1 reference

6 October 2017

287-296

1 reference

The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance

6 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB02083.X

Serum oestradiol-17 beta in women with benign and malignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB02083.X

L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB02083.X

Cyclophosphamide and reproductive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB02083.X

Circulating hormone concentrations in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB02083.X

Multiple late complications of therapy with cyclophosphamide, including ovarian destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB02083.X

Ovarian function in patients receiving adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB02083.X

Quantitative morphological investigations of the follicular system in women; variations at different ages

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer

20 May 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

Estradiol radioimmunoassay without chromatography: procedure, validation and normal values

20 May 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer

20 May 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies

20 May 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology

20 May 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

A Homologous Radioimmunoassay for Human Prolactin1

20 May 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

Cyclophosphamide-Induced Ovarian Failure

20 May 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB02083.X

20 May 2023

Identifiers

1 reference

6 October 2017

1 reference